(Q28379055)

English

Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production

scientific article

In more languages

Statements

scholarly article

0 references

Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production (English)

0 references

0 references

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

sodium stibogluconate

1 reference

based on heuristic

inferred from title

author name string

J Li

1

0 references

S Sutterwala

2

0 references

J P Farrell

3

0 references

language of work or name

0 references

publication date

August 1997

0 references

Infection and Immunity

0 references

65

0 references

8

0 references

3225-30

0 references

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

20 March 2017

Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

20 March 2017

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

20 March 2017

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

20 March 2017

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

7 April 2017

In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

29 September 2017

Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

2 June 2018

The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

27 November 2018

Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

27 November 2018

Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

27 November 2018

Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175456

27 November 2018

Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A sensitive immunochemical assay for biologically active MuIFN-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-4 induces a Th2 response in Leishmania major-infected mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical and immunological spectrum of American cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Treatment with Interferon- Alone in Visceral Leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9234779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28379055&oldid=1984138190"